You are not logged in.

Supply of iron (as ferric carboxymaltose) infusion

This tender is using the new split file responses feature on GETS. The agency has indicated that they would like to receive responses separated by price and non price components. Please keep this in mind when preparing your response for submission via GETS.

Details

RFx ID : 35544347
Tender Name : Supply of iron (as ferric carboxymaltose) infusion
Reference # :
Open Date : Wednesday, 18 November 2026 9:00 AM (Pacific/Auckland UTC+13:00)
Close Date  : Wednesday, 16 December 2026 2:00 PM (Pacific/Auckland UTC+13:00)
Tender Type : Request for Tenders (RFT)
Tender Coverage : Sole Agency  [?]
Categories :
  • 51000000 - Drugs and Pharmaceutical Products
Regions:
  • New Zealand
Exemption Reason : None
Required Pre-qualifications : None
Contact : Pharmac Procurement Team
procurement@Pharmac.govt.nz
Alternate Physical Delivery Address  :
Alternate Physical Fax Number  :
Overview

This is a competitive process for supply of iron (as ferric carboxymaltose) infusion for use in community and hospital settings.

Iron infusion is indicated for the treatment of iron-deficiency anaemia.


The proposed outcomes of this procurement are to make savings in the medicines budget, and to potentially widen or remove current funding criteria for iron (as ferric carboxymaltose) infusions.

Pharmac would reserve the right to widen access, or not, subject to budget availability and bids received.

The approximate gross annual expenditure of iron (as ferric carboxymaltose) inf. in the 2024/25 FYR was $9.5 million.

For current funding restrictions please view the Pharmaceutical Schedule: https://www.pharmac.govt.nz/tools-resources/pharmaceutical-schedule/community/


Crown Copyright © 2026